grant

Preventing and Understanding CHIP Evolution into AML: The role of the LY75 in the development of DNMT3A-mutant CH and associated myeloid neoplasms

Organization UKRILocation United Kingdom
UKRIUK ResearchGrantActive
Sign up free to applyApply link · pipeline · email alerts
— or —

Get email alerts for similar roles

Weekly digest · no password needed · unsubscribe any time

Description preview

Myeloid neoplasms (MN) affect ~10 per 100,000 individuals per year and remain lethal to the majority. Most cases of MN arise from the clonal expansion of an HSC and its progeny driven by MN-associated somatic mutations; a condition known as Clonal Hematopoiesis (CH) and develop many decades after the initial mutational event. DNMT3A is one of the…

🔒

Full details available on the Agency plan

Unlock the complete grant description, eligibility criteria, contract value, evaluation details and apply link — plus alerts, pipeline tracking, and CSV export.

Start 7-day free trial — $29.99/mo →

Agency Plan

7-day free trial

Unlock procurement & grants

Upgrade to access active tenders from World Bank, UNDP, ADB and more — with email alerts and pipeline tracking.

$29.99 / month

  • 🔔Email alerts for new matching tenders
  • 🗂️Track tenders in your pipeline
  • 💰Filter by contract value
  • 📥Export results to CSV
  • 📌Save searches with one click
Start 7-day free trial →
Preventing and Understanding CHIP Evolution into AML: The role of the LY75 in the development of DNMT3A-mutant CH and as | Dev Procure